MARSHALL & POPP, LLC for AMGEN USA INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to prescription drug value. S.2543: Prescription Drug Pricing Reduction Act of 2019. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19/S.3129: Lower Costs, More Cures Act of 2019. Biosimilars. 340B issues. Patents and protection of intellectual property issues. Issues related to the COVID-19 pandemic. H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. H.R.6201: Families First Coronavirus Response Act. H.R.748: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.